Esperante BV
General contacts
Investor type
PE
Founded
2004
AUM
-
Location
Netherlands
$1-5 m
Investment Ticket
3-5 years
Investment Horizon
Seed,
Series A
Investment Stage
Sale to strategic investor,
IPO
Exit Strategy
Investor profile last updated: 06 December, 2025
Profile
Esperante is a venture investment company controlled by C&P Group Holdings, a privately controlled life science interests group. The management, Board of Directors, Investment Committee and Advisors are significantly experienced in the operational management of life science companies, with a particular focus on the development, manufacturing and marketing of prescription pharmaceuticals and in vitro clinical diagnostic tests on a worldwide basis.
Industry
Region of investment
Contacts
Upgrade to see contacts
Name
Title
Email
Social Networks
If there are no contacts of this investor, please write to us, we will try to find them as
soon as possible and get back
to you!
FAQs about Esperante BV
Where is Esperante BV located?
Esperante BV is located in Netherlands.
When was Esperante BV founded?
Esperante BV was founded in 2004.
What sectors and industries does Esperante BV invest in?
Esperante BV invests in companies and startups in Healthcare Services, Other, Pharmaceuticals, Biotechnology, MedTech, Life Sciences, HealthTech.
What is Esperante BV geographical focus of investments?
Esperante BV invests in companies and startups in Europe.
At what stages of companies and startups does Esperante BV typically invest in?
Esperante BV invests in companies and startups at Seed, Series A.
What is the usual amount of Esperante BV investment?
Esperante BV usually invests $1-5 m on average.